Cerebras Systems prepares to unveil its inaugural quarterly results as a publicly traded entity Tuesday following market close. The announcement represents a pivotal milestone for investors who’ve watched the AI chip manufacturer’s turbulent journey since its May public debut.
Cerebras Systems Inc., CBRS
Shares launched at $185 and rocketed to $386 during debut trading. Volatility has defined the stock’s short public life—more than 19 of its 25 trading sessions have witnessed single-day price swings exceeding 3%. Monday’s closing price stood at $224.43.
Market participants anticipate another substantial price movement. Options activity indicates CBRS could swing as much as 13% either way through Friday’s close. Such movement would establish a ceiling near $254 or create a floor beneath $195.
Wall Street consensus points to Q1 revenue between $181 million and $183 million—an impressive 82% expansion compared to the prior-year quarter. The company remains unprofitable, with analysts projecting an adjusted per-share loss of 16 cents.
Central to the Cerebras investment thesis is its massive $20 billion multi-year cloud services agreement with OpenAI. The artificial intelligence leader currently leverages Cerebras’ infrastructure to power Codex-Spark, a specialized coding model.
However, there’s accounting complexity investors must grasp. Cerebras issued OpenAI warrants covering 33.4 million shares at virtually no cost. These warrants vest over time, and their value gets recorded as contra-revenue—effectively reducing reported revenue figures. During Q1, 4.5 million shares vested. Needham’s Quinn Bolton notes this charge remains modest initially but will escalate as OpenAI’s contract expands.
To provide clarity, Cerebras plans to disclose a “core revenue” metric that strips out contra-revenue adjustments.
The chipmaker has also secured a binding agreement with Amazon Web Services, potentially making AWS the first major cloud platform to deploy Cerebras technology.
Cerebras ended 2025 with a $24.6 billion backlog, dominated by the OpenAI commitment. Management anticipates converting $3.7 billion of this backlog into recognized revenue throughout 2026 and 2027.
A significant near-term risk emerges Thursday when a lock-up restriction expires. This event unlocks approximately 13% of IPO shares, allowing early backers and insiders to potentially liquidate positions. This increased float could pressure share prices downward.
The IPO itself represented just 15% of outstanding shares. Remaining shares stay restricted, with a secondary unlock scheduled for two days following the company’s Q2 earnings disclosure.
Eleven Wall Street analysts have published research coverage. Their average price objective reaches $294, with firms including Wedbush ($270), UBS ($300), and Morgan Stanley ($250) all recommending purchases. Analysts forecast core revenue hitting $7.2 billion by 2028, alongside adjusted earnings of $5.53 per share. Based on Monday’s closing price, shares trade at 41 times projected 2028 earnings.
The Q1 reporting period concluded in March, predating the public offering, meaning balance sheet and cash flow impacts from going public won’t appear in these results.
The post Cerebras (CBRS) Stock: What to Expect from Tuesday’s Debut Earnings Report appeared first on Blockonomi.


